Blood viscosity – The unifying cardiovascular disease risk biomarker

2026/01/16 by Erik Finlayson · 1 citation
Medicine · #Blood properties and coagulation #Cardiovascular Health and Disease Prevention #Diabetes, Cardiovascular Risks, and Lipoproteins

paper · doi:10.1016/j.mvr.2026.104904

openalex publication_date 2026/01/16 · crossref created 2026/01/16 · openalex created_date 2026/01/17 · crossref deposited 2026/01/23 · crossref issued 2026/03/01 · crossref published 2026/03/01 · crossref published-print 2026/03/01 · crossref indexed 2026/07/30 · openalex updated_date 2026/07/30

Abstract

• Blood viscosity is associated with all know cardiovascular risk factors. • The treatment of all known cardiovascular risk factors also decreases blood viscosity. • The measurement of blood viscosity may help to guide the treatment of cardiovascular disease risk.

Cited by

• High-Q magnetoelastic oscillators via amorphous magnetic microwires for wireless liquid sensing

Related

• Whole‐Blood Viscosity, Hematocrit and Plasma Protein in Normal Subjects at Different Ages
• Blood Rheology and Hemodynamics
• Blood Rheology and Hemodynamics
• Whole Blood Viscosity, Plasma Viscosity and Erythrocyte Aggregation in Nine Mammalian Species: Reference Values and Comparison of Data
• Enhancing Hemodynamic Parameter Estimations: Nonlinear Blood Behavior in 4D Flow MRI